Have you ever wondered what happens to the drugs you take after they enter your body? How do they reach their target organs or tissues? How long do they stay in your system? How are they transformed or eliminated? These are some of the questions that pharmacokinetics, a branch of pharmacology, tries to answer.
Pharmacokinetics (PK) is the study of the movement and change of substances in living organisms. These substances can be any chemicals that come from outside the body, such as drugs, pesticides, food additives, and cosmetics. PK analyzes how the body affects the drugs in terms of absorption, distribution, metabolism, and excretion (ADME). Conversely, pharmacodynamics (PD) studies how the drugs affect the body. Together, PK and PD determine the dose, benefit, and side effects of drugs, and are often studied together as PKPD.
PK is important for drug discovery and development, as it helps to optimize the drug delivery, efficacy, and safety. PK also helps to adjust the drug dosage and regimen for different patients, based on their demographic, physiological, and pathological characteristics, as well as their co-treatments. PK can also be applied to ecological toxicology, to study the impact of harmful chemicals on the biosphere and the environment.
PK uses mathematical models to describe and predict the concentration-time curves of drugs in the body. These models can be based on compartments, which are hypothetical spaces that represent different tissues or fluids in the body, or on non-compartmental methods, which rely on estimating the total exposure of the drug by calculating the area under the curve (AUC). PK models can be simple, such as the one-compartment model, which assumes that the drug is evenly distributed and eliminated from the body, or complex, such as the physiologically based pharmacokinetic (PBPK) model, which incorporates physiological information to simulate the drug behavior in the body.
One of the key concepts in PK is bioavailability, which is the fraction of the drug dose that reaches the systemic circulation. Bioavailability is influenced by many factors, such as the drug formulation, chemical form, route of administration, stability, and metabolism. Bioavailability is used to compare the drug exposure between different delivery methods, such as oral, intravenous, or transdermal. For example, intravenous injection provides the highest bioavailability, as the drug directly enters the bloodstream, while oral administration may reduce the bioavailability due to the first-pass effect, which is the metabolism of the drug by the liver before it reaches the circulation.
Another important concept in PK is clearance, which is the rate at which the drug is removed from the body. Clearance can be affected by the blood flow, the organ function, and the drug interactions. Clearance is used to calculate the elimination half-life, which is the time it takes for the drug concentration to decrease by half. The elimination half-life determines how often the drug needs to be administered to maintain a steady state, which is the condition where the drug intake and elimination are balanced.
PK is a fascinating and useful science that helps us understand how drugs work in our bodies. By applying PK principles and methods, we can improve the drug design, delivery, and dosing, and ultimately enhance the health and well-being of humans and other living beings.
